Eculizumab in kidney diseases

• Main Authors: Fatemeh Pour- (Author), Sara Assadiasl (Author)
• פורמט: ספר
• יצא לאור: Society of Diabetic Nephropathy Prevention, 2024-01-01T00:00:00Z.
• נושאים: article
• גישה מקוונת: Connect to this object online.

The C5 inhibitor monoclonal antibody, eculizumab, has been approved for the treatment of atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH); however, the efficacy and safety of this drug in treating other complement-related renal diseases has not yet been elucida...